Bank of America
VCNX

Bank of America’s Vaccinex, Inc. Common Stock VCNX Stock Holding History

Bank of America’s Portfolio VCNX Stock Details VCNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-24
Closed -$82 – 8530
2024
Q3 		$82 Buy
24
+16
+200% +$90 ﹤0.01% 7754
2024
Q2 		$52 Buy
+8
New +$48 ﹤0.01% 7833
2024
Q1 		– Hold
0
– -$3 – 8280
2023
Q4 		– Sell
-5
Closed -$59 – 7893
2023
Q3 		$76 Buy
+5
New +$254 ﹤0.01% 7481
2023
Q1 		– Hold
0
– -$34 – 8378
2022
Q4 		– Hold
0
– – – 7874
2021
Q2 		– Hold
0
– – – 8166
2021
Q1 		– Hold
0
– – – 7867
2020
Q3 		– Hold
0
– – – 7237
2020
Q2 		– Hold
0
– – – 7183
2019
Q3 		– Hold
0
– – – 7570
2019
Q2 		– Hold
0
– – – 7464

Other funds holding VCNX

Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Bank of America's VCNX Position: Q4 2024 in Review

Bank of America sold out of Vaccinex, Inc. Common Stock (VCNX) in Q4 2024, closing a stake of 24 shares — an estimated $82 sold.

Bank of America first reported a position in VCNX in Q3 2023 and held it in 3 quarters. The position peaked at $82 in Q3 2024. 1 fund tracked by Wall St. Rank holds VCNX as of Q4 2024.

  • Bank of America reported no remaining Vaccinex, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Bank of America sold 24 Vaccinex, Inc. Common Stock shares in Q4 2024, an estimated $82.
  • Bank of America first reported a position in Vaccinex, Inc. Common Stock in Q3 2023 and held it in 3 quarters.
  • Bank of America's Vaccinex, Inc. Common Stock position peaked at $82 in Q3 2024.
  • 1 fund tracked by Wall St. Rank held Vaccinex, Inc. Common Stock as of Q4 2024.

Based on Bank of America's 13F filing for Q4 2024, filed 14 Feb 2025.